Farhat M, Guerreschi P, Morell-Dubois S, Deken V, Labreuche J, Sanges S
J Scleroderma Relat Disord. 2024; 9(2):124-133.
PMID: 38910601
PMC: 11188849.
DOI: 10.1177/23971983241231620.
Mills T, Price E, Aggarwal V, Del Galdo F, Walker L
J Scleroderma Relat Disord. 2024; 9(2):86-98.
PMID: 38910600
PMC: 11188842.
DOI: 10.1177/23971983231193515.
Frommer M, Langridge B, Beedie A, Jasionowska S, Awad L, Denton C
Cells. 2024; 13(8.
PMID: 38667308
PMC: 11049044.
DOI: 10.3390/cells13080693.
Luch S, Men P, Fischer G, Wu A
Case Rep Pediatr. 2023; 2023:3918638.
PMID: 37636244
PMC: 10449588.
DOI: 10.1155/2023/3918638.
Frommer M, Langridge B, Awad L, Jasionowska S, Denton C, Abraham D
Cells. 2023; 12(13).
PMID: 37443817
PMC: 10341100.
DOI: 10.3390/cells12131784.
Systemic Sclerosis Patients Experiencing Mindfulness-Based Stress Reduction Program: The Beneficial Effect on Their Psychological Status and Quality of Life.
El Aoufy K, Pezzutto A, Pollina A, Rasero L, Bambi S, Bellando-Randone S
Int J Environ Res Public Health. 2023; 20(3).
PMID: 36767877
PMC: 9915443.
DOI: 10.3390/ijerph20032512.
Diagnosis and Management of Cutaneous Manifestations of Autoimmune Connective Tissue Diseases.
Goldman N, Han J, LaChance A
Clin Cosmet Investig Dermatol. 2022; 15:2285-2312.
PMID: 36320926
PMC: 9618245.
DOI: 10.2147/CCID.S360801.
Differences in symptom experience among patients with systemic sclerosis: a cluster analytic approach to identifying subgroups.
Murphy S, Chen Y, Lee Y, Carns M, Aren K, Korman B
Rheumatology (Oxford). 2022; 62(SI):SI64-SI73.
PMID: 35920770
PMC: 9910572.
DOI: 10.1093/rheumatology/keac444.
Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS).
Pettersson H, Alexanderson H, Poole J, Varga J, Regardt M, Russell A
Best Pract Res Clin Rheumatol. 2021; 35(3):101695.
PMID: 34217607
PMC: 8478716.
DOI: 10.1016/j.berh.2021.101695.
Correlations Between Clinical Features and Mouth Opening in Patients With Systemic Sclerosis.
Turk I, Cuzdan N, Ciftci V, Arslan D, Unal I
Arch Rheumatol. 2020; 35(2):196-204.
PMID: 32851368
PMC: 7406162.
DOI: 10.46497/ArchRheumatol.2020.7434.
Feasibility study of stem-cell enriched autologous lipotransfer to treat oro-facial fibrosis in systemic sclerosis (Sys-Stem): Protocol for open-label randomised controlled trial.
Jeon F, Griffin M, Denton C, Butler P
Int J Surg Protoc. 2020; 23:6-10.
PMID: 32803023
PMC: 7419663.
DOI: 10.1016/j.isjp.2020.07.002.
Illness perceptions, risk perceptions and worries in patients with early systemic sclerosis: A focus group study.
van Leeuwen N, Boonstra M, Huizinga T, Kaptein A, de Vries-Bouwstra J
Musculoskeletal Care. 2020; 18(2):177-186.
PMID: 31984643
PMC: 7318332.
DOI: 10.1002/msc.1453.
Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis.
Almadori A, Griffin M, Ryan C, Hunt D, Hansen E, Kumar R
PLoS One. 2019; 14(7):e0218068.
PMID: 31314805
PMC: 6636710.
DOI: 10.1371/journal.pone.0218068.
Malnutrition, associated clinical factors, and depression in systemic sclerosis: a cross-sectional study.
Turk I, Cuzdan N, Ciftci V, Arslan D, Dogan M, Unal I
Clin Rheumatol. 2019; 39(1):57-67.
PMID: 31129793
DOI: 10.1007/s10067-019-04598-y.
Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.
Park E, Strand V, Oh Y, Song Y, Lee E
Arthritis Res Ther. 2019; 21(1):61.
PMID: 30770765
PMC: 6377714.
DOI: 10.1186/s13075-019-1842-x.
Factors related to alexithymia in patients with systemic sclerosis: a tight relationship with facial image dissatisfaction.
Basta F, Margiotta D, Mazzuca C, Batani V, Dolcini G, Moras P
Rheumatol Int. 2018; 39(3):461-467.
PMID: 30498976
DOI: 10.1007/s00296-018-4214-y.
Risk association between scleroderma disease characteristics, periodontitis, and tooth loss.
Isola G, Williams R, Lo Gullo A, Ramaglia L, Matarese M, Iorio-Siciliano V
Clin Rheumatol. 2017; 36(12):2733-2741.
PMID: 28988297
DOI: 10.1007/s10067-017-3861-9.
Improvement of Microstomia in Scleroderma after Carbon Dioxide Laser Treatment.
Bennani I, Lopez R, Bonnet D, Prevot G, Constantin A, Chauveau D
Case Rep Dermatol. 2016; 8(2):142-50.
PMID: 27403126
PMC: 4924459.
DOI: 10.1159/000445821.
Exploring Sources of Emotional Distress among People Living with Scleroderma: A Focus Group Study.
Gumuchian S, Pelaez S, Delisle V, Carrier M, Jewett L, El-Baalbaki G
PLoS One. 2016; 11(3):e0152419.
PMID: 27008209
PMC: 4805283.
DOI: 10.1371/journal.pone.0152419.
Development and Validation of the Body Concealment Scale for Scleroderma.
Jewett L, Malcarne V, Kwakkenbos L, Harcourt D, Rumsey N, Korner A
Arthritis Care Res (Hoboken). 2015; 68(8):1158-65.
PMID: 26663624
PMC: 5517295.
DOI: 10.1002/acr.22819.